AMPH
Amphastar Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$23.62
−0.84%Forward multiples
Based on analyst estimates
- P/E forward
- 7.42x
- P/E 2026E
- 7.97x
- P/E 2027E
- 7.45x
- P/E 2028E
- 7.00x
- P/S forward
- 1.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.57x
- PEG TTM
- 0.16x
- Price / book
- 1.31x
- Price / sales
- 1.38x
- Price / cash flow
- 5.44x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 1.92x
- EV / EBITDA
- 8.03x
- EV / EBIT
- 12.28x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026